Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China
· Delayed Price · Currency is CNY 15.42
+0.20 (1.31%)
Apr 29, 2026, 3:04 PM CST
SHE:300181 Revenue
Zhejiang Jolly Pharmaceutical Co.,LTD had revenue of 897.80M CNY in the quarter ending March 31, 2026, with 8.90% growth. This brings the company's revenue in the last twelve months to 3.11B, up 14.10% year-over-year. In the year 2025, Zhejiang Jolly Pharmaceutical Co.,LTD had annual revenue of 3.04B with 17.96% growth.
Revenue (ttm)
3.11B
Revenue Growth
+14.10%
P/S Ratio
3.39
Revenue / Employee
1.47M
Employees
2,125
Market Cap
10.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.04B | 462.89M | 17.96% |
| Dec 31, 2024 | 2.58B | 635.44M | 32.71% |
| Dec 31, 2023 | 1.94B | 137.29M | 7.61% |
| Jan 1, 2023 | 1.81B | 347.76M | 23.86% |
| Jan 1, 2022 | 1.46B | 366.52M | 33.60% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai InnoStar Bio-tech | 811.33M |
| Yifan Pharmaceutical | 5.06B |
| CSPC Hunan Jingfeng Pharmaceutical | 393.19M |
| Aurora Optoelectronics | 465.12M |
| GuangYuYuan Chinese Herbal Medicine | 1.44B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.09B |
| Nanjing Pharmaceutical Group Company | 54.96B |
| Chongqing Lummy Pharmaceutical | 759.50M |